Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hondrospey
- Development stage
- Unknown
- Lead developer
- Spey Medical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Hondrospey is a dietary supplement developed by Spey Medical to reduce the symptoms of osteoarthritis, including joint pain, stiffness, and reduced flexibility. Formulated as an effervescent tablet, it contains a combination of glucosamine sulfate, chondroitin sulfate, methylsulfonylmethane (MSM), and ginger extract. These active ingredients act synergistically as chondroprotective, anti-inflammatory, and analgesic agents to support joint and cartilage health, strengthen tendons, and improve overall joint mobility.
- Brand names
- Hondrospey
- Other names
- Хондроспей
Beyond the preview
Go deeper on Hondrospey.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hondrospey.